"
Reserpine-Induced Progressive Parkinsonism in Mice Predisposed and Non-Predisposed to Depressive-Like Behavior"
written by Manuela B. L. Soares, Leonardo B. Lopes-Silva, Marcela Becegato, Vinicius S. Bioni, Alvaro C. Lima, Gabriela M. Ferreira, Ywlliane Meurer, Regina H. Silva,
published by
Journal of Behavioral and Brain Science,
Vol.11 No.11, 2021
has been cited by the following article(s):
|
[1]
|
Preventive beneficial effects of cannabidiol in a reserpine-induced progressive model of parkinsonism
Frontiers in Pharmacology,
2025
DOI:10.3389/fphar.2025.1539783
|
|
|
|
|
[2]
|
Animal Approaches to Studying Risk Factors for Parkinson’s Disease: A Narrative Review
Brain Sciences,
2024
DOI:10.3390/brainsci14020156
|
|
|
|
|
[3]
|
Neuroprotective potential of Afzelin: A novel approach for alleviating catalepsy and modulating Bcl-2 expression in Parkinson's disease therapy
Saudi Pharmaceutical Journal,
2024
DOI:10.1016/j.jsps.2023.101928
|
|
|
|
|
[4]
|
Sleep deprivation induces late deleterious effects in a pharmacological model of Parkinsonism
Experimental Brain Research,
2024
DOI:10.1007/s00221-024-06811-0
|
|
|
|